ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Changes For Computerized Systems And Electronic Data

  Explore several modifications introduced in the updated guidelines by the European Medicines Agency regarding computerized systems and electronic data in clinical trials.

• Implementing Caregiver Assessments: Key Considerations

  When caregivers are involved in a clinical trial, remember to utilize these tactics to ensure that the completion of Observer Reported Outcomes is user-friendly and upholds data quality standards.

• Navigating eCOA Licensing And Localization In Clinical Trials

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• Achieving Faster, Simpler Validation Through Crowdsource UAT

  An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.

• eConsent: The Missing Ingredient To More Engaging Clinical Trials

  Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.

• How Can Sponsors Enable Research-Naïve Clinical Trial Sites

  Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.

• How eSource Reduced Benchmark's Protocol Deviations By Almost 40%

  Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.

• Implementing eSource: A Guide For Operations And Technology Roles

  By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.

• Making The Lives Of Patients And Research Sites Easier

  Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.

• The Value Of Tokenizing Clinical Development Data

  Most use cases of real-world data don’t require tokenization to deliver value. However, given industry challenges and the influx of information, see how ROI can be achieved from trial data tokenization.